Astro Med 8K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT
(DATE OF EARLIEST EVENT REPORTED)
MAY 13, 2003
ASTRO-MED, INC
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
COMMISSION FILE NUMBER 0-13200
RHODE ISLAND 05-0318215
(STATE OR OTHER JURISDICTION OF (IRS EMPLOYER IDENTIFICATION
INCORPORATION OR ORGANIZATION) NUMBER)
600 EAST GREENWICH AVENUE, WEST WARWICK, RI 02893
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES, INCLUDING ZIP CODE)
(401-828-4000)
(REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibit
Exhibit no. Exhibit
99.1 Press Release dated May 13, 2003
ITEM 9. REGULATION FD DISCLOSURE AND ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
In accordance with Securities and Exchange Commission Release No. 33-8126,
the following information, which is intended to be furnished under Item 12,
"Results of Operations and Financial Condition", is instead being furnished
under Item 9, "Regulation FD Disclosure." This information shall not be deemed
"filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), or incorporated by reference in any filing under
the Securities Act of 1933, as amended, or the Exchange Act, except as shall be
expressly set forth by specific reference in such a filing.
On May 13, 2003, Astro-Med, Inc. issued a press release in which it
disclosed unaudited financial information related to first quarter consolidated
earnings. A copy of the press release relating to such announcement, dated May
13, 2003, is attached hereto as Exhibit 99.1 and is incorporated herein by
reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrants have duly caused this report to be signed on their behalf by the
undersigned thereunto duly authorized.
DATE: May 16, 2003 ASTRO-MED, INC.
By: /s/ Joseph P. O'Connell
------------------------
Vice President and Treasurer Chief Financial Officer
INDEX TO EXHIBITS
Exhibit No. Exhibit
----------- -------
99.1 Press Release Dated May 13, 2003
Exhibit 99.1 - Press Release
----------------------------
--------------------------------------------------------------------------------
PRESS RELEASE
--------------------------------------------------------------------------------
[OBJECT OMITTED]
600 East Greenwich Avenue
West Warwick, Rhode Island 02893
Astro-Med Estimates Strong Sales and Profit for the First Quarter
Contact: Albert W. Ondis, CEO
Joseph P. O'Connell, CFO May 13, 2003
Astro-Med, Inc.
(401) 828-4000
West Warwick, RI -- Astro-Med, Inc. (NASDAQ:ALOT) announced today it expects to
report sales of $13.2 million for the First Quarter ended May 3, 2003, an
increase of 16% over the $11.4 million reported for the corresponding quarter of
the prior year. The Company anticipates net income of approximately $500,000,
equal to 12 cents per share, for the Quarter compared to a net loss of $632,000,
equal to 15 cents per share, for the corresponding Quarter of the prior year.
Commenting on the First Quarter, Albert W. Ondis, Chairman and Chief Executive
Officer stated: "Coming on the heels of the excellent operating results of the
Fourth Quarter, when we reported sales of $12.9 million, this quarter
exemplifies continuing progress. We are very gratified to report that incoming
new orders, including the Airbus order that we recently announced, reached a
record $15.0 million in the quarter. This is an all-time high and is a further
sign that our new products are being well received in the marketplace."
The Company's actual results for the First Quarter will be released on Tuesday,
May 20, 2003 and management will discuss the results in detail during our
conference call on May 21, 2003 at 11:00 AM EDT. The conference will be
broadcast in real time over the Internet. Access is available through the
Company's website at www.astromed.com.
Astro-Med, Inc. is a leading manufacturer of high tech specialty printing
systems, electronic medical instrumentation, and test and measurement
instruments employed around the world in a wide range of industrial, scientific
and medical applications.
# # #
Safe Harbor Statement
This news release contains forward-looking statements, and actual results may
vary from those expressed or implied herein. Factors that could affect these
results include those mentioned in Astro-Med's FY2003 annual report and its
annual and quarterly filings with the Securities and Exchange Commission.